One platform for drug and RNA discovery.
BrainOmega's foundation models power two products, Drug Discovery and RNA Discovery, behind one sign-in. Generate candidates, evaluate them on the properties that matter and prioritise them for the lab, with the evidence for every result shown beside it.
One system, not a stack of point tools.
Three parts that work together to take a research question to a shortlist your team can defend.
Foundation Model
Models built and trained by BrainOmega for chemistry and RNA biology. They generate candidates and predict the properties that decide which go forward.
- Generation of molecules and sequences
- Property prediction, including ADMET
- A confidence for every prediction
Drug Discovery
A Generative AI workspace for small-molecule programmes, from target to shortlist.
- Identify and assess targets
- Design and explore molecules in 3D
- Prioritise candidates for further testing
RNA Discovery
Discovery across RNA classes, from microRNAs and tRNA fragments to circular RNAs and mRNA neoantigens.
- Characterise a sequence you already have
- Scan public data for new candidates
- The rule and evidence behind every verdict
From a research question to a shortlist you can defend.
Four steps your team can adopt without rebuilding its existing stack.
Frame the question
Set the target, the modality and the constraints that matter to your programme.
Generate
Our models propose candidate molecules or RNA sequences that fit the brief.
Evaluate
Each candidate is scored on the properties that decide its fate, with evidence and confidence shown.
Prioritise
Rank, compare and export the shortlist for your scientists and your lab.
See it on one of your own questions.
Bring a target, an RNA of interest or an existing series. We will walk your team through the platform on it, prediction by prediction.